Predictors of Response to Mood Stabilizers
The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Although lithium remains the preferred treatment of bipolar disorder, only 60 to 80% of patients with the classic presentation have an adequate response to this drug. When the response rate to lithium is considered across the entire spectrum of bipolar disorders, this rate probably decreases to 50%. Natural history, illness subtype, and comorbidity are all important general predictors of response to treatment. At present, the only predictors that seem to differentially favor divalproex, and possible, carbamazepine over lithium are mixed states and rapid cycling. An overview of clinical presentations that predict general and differential response to mood stabilizers is provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients who respond well to lithium treatment usually have an episodic remitting pre‐treatment clinical course, a family history of BD (especially BD responsive to lithium), low rates of comorbidity (especially anxiety and substance abuse disorders), and a pattern of mania‐depression‐euthymia in biphasic episodes, as well as a typical clinical presentation.414, 415, 416”
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Regier, D. A. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800350011002 · Cited by 1,737
Time-related predictors of suicide in major affective disorder
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.9.1189 · Cited by 1,058
Psychopathology in Hospitalized Alcoholics
Hesselbrock, M. N. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790340028004 · Cited by 715
Akiskal, H. S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950140032004 · Cited by 679
Antidepressant-induced mania and cycle acceleration: a controversy revisited
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1130 · Cited by 608
Outcome in Mania: A 4-Year Prospective Follow-up of 75 Patients Utilizing Survival Analysis
Tohen, M. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240026005 · Cited by 532
Clinical Factors in Lithium Carbonate Prophylaxis Failure
Dunner, D. L. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760080077013 · Cited by 514
Course of the Manic-Depressive Cycle and Changes Caused by Treatments
Kukopulos, A., Reginaldi, D., Laddomada, P., Floris, G., Serra, G., & Tondo, L. (2008) · Pharmacopsychiatry · doi:10.1055/s-2007-1019628 · Cited by 436
Research works printed but not linked: 9
- Zis, 1980, Psychopharmacol Bull, 16, 47
- Gaviria, 1982, Psychiatr J Univ Ott, 7, 190
- Abou-Saleh, 1990, Lithium, 1, 27
- Himmelhoch, 1986, ull, 22, 613
- Lerer, 1987, J Clin Psychiatry, 48, 89
- Stromgren, 1985, Psychiatr Dev, 4, 349
- Inoue, 1981, Folia Psychiatr Neurol Jpn, 35, 465
- Okuma, 1973, Folia Psychiatr Neurol Jpn, 27, 283
- Dunner, 1976, Biol Psychiatry, 11, 31
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationThe Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
Sachs, G. S., PRINTZ, D. J., Kahn, D. A., Carpenter, D. P., & Docherty, J. P. (2000) · PubMed · Cited by 534
A review of psychosocial outcome in patients with bipolar disorder
MacQueen, G. M., Young, L. T., & Joffe, R. T. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00059.x · Cited by 354
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
Alda, M. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.4 · Cited by 315
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
Macritchie, K., Geddes, J., Scott, J., Haslam, D. R., & Goodwin, G. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003196 · Cited by 263
Metadata
- Authors
- CALABRESE, J. R., FATEMI, S. H., KUJAWA, M., & WOYSHVILLE, M. J.
- Affiliations
- University Hospitals of Cleveland (US)
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 1996-04
- Volume
- 16
- Issue
- SUPPLEMENT 1
- Pages
- 24S-31S
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1978904708
- Cited by
- 95
- References
- 78
- Citations by year
- 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- mood stabilizers, predictors of treatment response, bipolar disorder, lithium, divalproex, carbamazepine, mixed states, rapid cycling, comorbidities, natural history (disease)
- MeSH terms
- Bipolar Disorder, Carbamazepine, Clinical Trials as Topic, Humans, Lithium, Valproic Acid, Comorbidity, Treatment Outcome, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of Response to Mood Stabilizers. https://app.cochat.ai/papers/10.1097/00004714-199604001-00004
- The paper
- CALABRESE, J. R., FATEMI, S. H., KUJAWA, M., & WOYSHVILLE, M. J. (1996). Predictors of Response to Mood Stabilizers. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199604001-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.